SOLVSolventum

Certain relationships and related person transactions

“Solventum has adopted a related person transaction process that is administered by the Governance Committee. This process applies to any transaction or series of transactions in which Solventum or a subsidiary is a participant, the amount involved exceeds $120,000, a related person (as that term is defined in Item 404(a) of Regulation S-K) has a direct or indirect material interest, and the transaction is required to be disclosed under Item 404(a) of Regulation S-K. Transactions that fall within this definition are referred to the Governance Committee for review and approval or other action, including ratification. Based on its consideration of all of the relevant facts and circumstances, the Governance Committee will decide whether or not to approve a transaction and will approve only those transactions that are in the best interests of Solventum and its shareholders. Any Governance Committee member who is a related person with respect to a transaction under review will not participate in the deliberations or vote respecting such approval, except that such a director may be counted in determining the presence of a quorum at a meeting at which the committee considers the transaction. On an annual basis, each director and executive officer is obligated to complete a director and officer questionnaire that requires disclosure of any transactions with us in which the director or executive officer, or any member of his or her immediate family, has an interest.”

Read it in the proxy ↗

Certain relationships and related person transactions

“Under our Code of Conduct, which is available on our website at www.solventum.com, and related policies and procedures, actual or potential conflicts of interest involving any other employee must be disclosed promptly to the Chair of the Governance Committee and the Chief Corporate & Legal Affairs Officer.”

Read it in the proxy ↗

Certain relationships and related person transactions

“Doug Jones, MedSurg VP Sales US & Canada, is the brother in law of Bryan Hanson, our Chief Executive Officer. Mr. Jones currently receives annual compensation - including base salary and bonus - of approximately $536,200. Mr. Jones also receives certain other benefits, including awards of equity, customary to similar positions within the Company. In 2025, such equity award had a target value of $300,000. Mr. Jones’ employment was approved by the Governance Committee in accordance with our hiring standards after a robust search and process. The amounts paid to Mr. Jones were commensurate with those paid to employees in similar positions and responsibility levels.”

Read it in the proxy ↗